IBDEI33O ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,49513,1,3,0)
;;=3^NHL NEC,Extranodal & Solid Organ
;;^UTILITY(U,$J,358.3,49513,1,4,0)
;;=4^C85.89
;;^UTILITY(U,$J,358.3,49513,2)
;;=^5001730
;;^UTILITY(U,$J,358.3,49514,0)
;;=C79.51^^191^2467^33
;;^UTILITY(U,$J,358.3,49514,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49514,1,3,0)
;;=3^Secondary Malig Neop Bone
;;^UTILITY(U,$J,358.3,49514,1,4,0)
;;=4^C79.51
;;^UTILITY(U,$J,358.3,49514,2)
;;=^5001350
;;^UTILITY(U,$J,358.3,49515,0)
;;=C79.52^^191^2467^32
;;^UTILITY(U,$J,358.3,49515,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49515,1,3,0)
;;=3^Secondary Malig Neop Bone Marrow
;;^UTILITY(U,$J,358.3,49515,1,4,0)
;;=4^C79.52
;;^UTILITY(U,$J,358.3,49515,2)
;;=^5001351
;;^UTILITY(U,$J,358.3,49516,0)
;;=C92.00^^191^2467^26
;;^UTILITY(U,$J,358.3,49516,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49516,1,3,0)
;;=3^Myelobl Leuk,Acute,No Remiss
;;^UTILITY(U,$J,358.3,49516,1,4,0)
;;=4^C92.00
;;^UTILITY(U,$J,358.3,49516,2)
;;=^5001789
;;^UTILITY(U,$J,358.3,49517,0)
;;=C92.40^^191^2467^31
;;^UTILITY(U,$J,358.3,49517,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49517,1,3,0)
;;=3^Promyelocyt Leuk,Acute,No Remiss
;;^UTILITY(U,$J,358.3,49517,1,4,0)
;;=4^C92.40
;;^UTILITY(U,$J,358.3,49517,2)
;;=^5001801
;;^UTILITY(U,$J,358.3,49518,0)
;;=C92.50^^191^2467^28
;;^UTILITY(U,$J,358.3,49518,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49518,1,3,0)
;;=3^Myelomonocyt Leuk,Acute,No Remiss
;;^UTILITY(U,$J,358.3,49518,1,4,0)
;;=4^C92.50
;;^UTILITY(U,$J,358.3,49518,2)
;;=^5001804
;;^UTILITY(U,$J,358.3,49519,0)
;;=C78.7^^191^2467^37
;;^UTILITY(U,$J,358.3,49519,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49519,1,3,0)
;;=3^Secondary Malig Neop Liver & Intrahep BD
;;^UTILITY(U,$J,358.3,49519,1,4,0)
;;=4^C78.7
;;^UTILITY(U,$J,358.3,49519,2)
;;=^5001339
;;^UTILITY(U,$J,358.3,49520,0)
;;=C91.10^^191^2467^5
;;^UTILITY(U,$J,358.3,49520,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49520,1,3,0)
;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
;;^UTILITY(U,$J,358.3,49520,1,4,0)
;;=4^C91.10
;;^UTILITY(U,$J,358.3,49520,2)
;;=^5001765
;;^UTILITY(U,$J,358.3,49521,0)
;;=D46.9^^191^2467^27
;;^UTILITY(U,$J,358.3,49521,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49521,1,3,0)
;;=3^Myelodysplastic Syndrome,Unspec
;;^UTILITY(U,$J,358.3,49521,1,4,0)
;;=4^D46.9
;;^UTILITY(U,$J,358.3,49521,2)
;;=^334031
;;^UTILITY(U,$J,358.3,49522,0)
;;=C79.31^^191^2467^34
;;^UTILITY(U,$J,358.3,49522,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49522,1,3,0)
;;=3^Secondary Malig Neop Brain
;;^UTILITY(U,$J,358.3,49522,1,4,0)
;;=4^C79.31
;;^UTILITY(U,$J,358.3,49522,2)
;;=^5001347
;;^UTILITY(U,$J,358.3,49523,0)
;;=C79.32^^191^2467^35
;;^UTILITY(U,$J,358.3,49523,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49523,1,3,0)
;;=3^Secondary Malig Neop Cerebral Meninges
;;^UTILITY(U,$J,358.3,49523,1,4,0)
;;=4^C79.32
;;^UTILITY(U,$J,358.3,49523,2)
;;=^5001348
;;^UTILITY(U,$J,358.3,49524,0)
;;=G89.3^^191^2467^30
;;^UTILITY(U,$J,358.3,49524,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49524,1,3,0)
;;=3^Neoplasm Related Pain
;;^UTILITY(U,$J,358.3,49524,1,4,0)
;;=4^G89.3
;;^UTILITY(U,$J,358.3,49524,2)
;;=^5004159
;;^UTILITY(U,$J,358.3,49525,0)
;;=C79.82^^191^2467^36
;;^UTILITY(U,$J,358.3,49525,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49525,1,3,0)
;;=3^Secondary Malig Neop Genital Organs
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI33O 3762 printed Dec 13, 2024@02:41:11 Page 2
IBDEI33O ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,49513,1,3,0)
+2 ;;=3^NHL NEC,Extranodal & Solid Organ
+3 ;;^UTILITY(U,$J,358.3,49513,1,4,0)
+4 ;;=4^C85.89
+5 ;;^UTILITY(U,$J,358.3,49513,2)
+6 ;;=^5001730
+7 ;;^UTILITY(U,$J,358.3,49514,0)
+8 ;;=C79.51^^191^2467^33
+9 ;;^UTILITY(U,$J,358.3,49514,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,49514,1,3,0)
+12 ;;=3^Secondary Malig Neop Bone
+13 ;;^UTILITY(U,$J,358.3,49514,1,4,0)
+14 ;;=4^C79.51
+15 ;;^UTILITY(U,$J,358.3,49514,2)
+16 ;;=^5001350
+17 ;;^UTILITY(U,$J,358.3,49515,0)
+18 ;;=C79.52^^191^2467^32
+19 ;;^UTILITY(U,$J,358.3,49515,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,49515,1,3,0)
+22 ;;=3^Secondary Malig Neop Bone Marrow
+23 ;;^UTILITY(U,$J,358.3,49515,1,4,0)
+24 ;;=4^C79.52
+25 ;;^UTILITY(U,$J,358.3,49515,2)
+26 ;;=^5001351
+27 ;;^UTILITY(U,$J,358.3,49516,0)
+28 ;;=C92.00^^191^2467^26
+29 ;;^UTILITY(U,$J,358.3,49516,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,49516,1,3,0)
+32 ;;=3^Myelobl Leuk,Acute,No Remiss
+33 ;;^UTILITY(U,$J,358.3,49516,1,4,0)
+34 ;;=4^C92.00
+35 ;;^UTILITY(U,$J,358.3,49516,2)
+36 ;;=^5001789
+37 ;;^UTILITY(U,$J,358.3,49517,0)
+38 ;;=C92.40^^191^2467^31
+39 ;;^UTILITY(U,$J,358.3,49517,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,49517,1,3,0)
+42 ;;=3^Promyelocyt Leuk,Acute,No Remiss
+43 ;;^UTILITY(U,$J,358.3,49517,1,4,0)
+44 ;;=4^C92.40
+45 ;;^UTILITY(U,$J,358.3,49517,2)
+46 ;;=^5001801
+47 ;;^UTILITY(U,$J,358.3,49518,0)
+48 ;;=C92.50^^191^2467^28
+49 ;;^UTILITY(U,$J,358.3,49518,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,49518,1,3,0)
+52 ;;=3^Myelomonocyt Leuk,Acute,No Remiss
+53 ;;^UTILITY(U,$J,358.3,49518,1,4,0)
+54 ;;=4^C92.50
+55 ;;^UTILITY(U,$J,358.3,49518,2)
+56 ;;=^5001804
+57 ;;^UTILITY(U,$J,358.3,49519,0)
+58 ;;=C78.7^^191^2467^37
+59 ;;^UTILITY(U,$J,358.3,49519,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,49519,1,3,0)
+62 ;;=3^Secondary Malig Neop Liver & Intrahep BD
+63 ;;^UTILITY(U,$J,358.3,49519,1,4,0)
+64 ;;=4^C78.7
+65 ;;^UTILITY(U,$J,358.3,49519,2)
+66 ;;=^5001339
+67 ;;^UTILITY(U,$J,358.3,49520,0)
+68 ;;=C91.10^^191^2467^5
+69 ;;^UTILITY(U,$J,358.3,49520,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,49520,1,3,0)
+72 ;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
+73 ;;^UTILITY(U,$J,358.3,49520,1,4,0)
+74 ;;=4^C91.10
+75 ;;^UTILITY(U,$J,358.3,49520,2)
+76 ;;=^5001765
+77 ;;^UTILITY(U,$J,358.3,49521,0)
+78 ;;=D46.9^^191^2467^27
+79 ;;^UTILITY(U,$J,358.3,49521,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,49521,1,3,0)
+82 ;;=3^Myelodysplastic Syndrome,Unspec
+83 ;;^UTILITY(U,$J,358.3,49521,1,4,0)
+84 ;;=4^D46.9
+85 ;;^UTILITY(U,$J,358.3,49521,2)
+86 ;;=^334031
+87 ;;^UTILITY(U,$J,358.3,49522,0)
+88 ;;=C79.31^^191^2467^34
+89 ;;^UTILITY(U,$J,358.3,49522,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,49522,1,3,0)
+92 ;;=3^Secondary Malig Neop Brain
+93 ;;^UTILITY(U,$J,358.3,49522,1,4,0)
+94 ;;=4^C79.31
+95 ;;^UTILITY(U,$J,358.3,49522,2)
+96 ;;=^5001347
+97 ;;^UTILITY(U,$J,358.3,49523,0)
+98 ;;=C79.32^^191^2467^35
+99 ;;^UTILITY(U,$J,358.3,49523,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,49523,1,3,0)
+102 ;;=3^Secondary Malig Neop Cerebral Meninges
+103 ;;^UTILITY(U,$J,358.3,49523,1,4,0)
+104 ;;=4^C79.32
+105 ;;^UTILITY(U,$J,358.3,49523,2)
+106 ;;=^5001348
+107 ;;^UTILITY(U,$J,358.3,49524,0)
+108 ;;=G89.3^^191^2467^30
+109 ;;^UTILITY(U,$J,358.3,49524,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,49524,1,3,0)
+112 ;;=3^Neoplasm Related Pain
+113 ;;^UTILITY(U,$J,358.3,49524,1,4,0)
+114 ;;=4^G89.3
+115 ;;^UTILITY(U,$J,358.3,49524,2)
+116 ;;=^5004159
+117 ;;^UTILITY(U,$J,358.3,49525,0)
+118 ;;=C79.82^^191^2467^36
+119 ;;^UTILITY(U,$J,358.3,49525,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,49525,1,3,0)
+122 ;;=3^Secondary Malig Neop Genital Organs
